The WHO Prequalification of In Vitro Diagnostics Assessment Team would like to invite manufacturers to submit an EOI for the product evaluation of urgently needed In-Vitro Diagnostics (IVDs) by the WHO ERPD panel. The invitation specifically pertains to several types of dengue IVDs. Additionally, the document provides the required specifications or quality assurance criteria for these IVDs.
Manufacturers whose IVDs are intended for diagnosis of acute dengue infection and who meet all of the required specifications and quality assurance criteria defined below are encouraged to apply by completing a product submission form (questionnaire) and necessary supporting documentation to ERPD-NTD@who.int.
WHO PQ team will coordinate the ERPD review process and provide recommendations for procurement decisions and facilitate the supply of IVDs by WHO NTD, and WHE OSL.
Submission should be submitted by electronic means (either via email or web-based download service) to ERPD-NTD@who.int by the specified deadline (7 July 2024).
For more information, please refer to the link below: